MacroGenics
The Sr. Manager, Business Development at MacroGenics will serve as the operational bridge between early-stage discovery, clinical development, and corporate partnerships, focusing on immuno‑oncology and novel antibody‑based biologics. The role involves shaping pipeline strategy, managing alliance relationships, and guiding product planning across research, clinical, regulatory, and commercial functions.
MacroGenics is a clinical-stage biopharmaceutical company developing next-generation antibody-based therapies to improve the lives of cancer patients. The company is advancing a broad pipeline of novel product candidates spanning oncology, hematology, and autoimmune applications, including antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and T-cell engagers. MacroGenics has a proven track record of developing FDA-approved therapies in collaboration with global biopharmaceutical partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MacroGenics.
73% above the average for this role